Garrett Ingrando

Garrett Ingrando is an accomplished marketing leader with extensive experience in the biopharmaceutical industry, currently serving as the Head of Marketing for North America at Alnylam Pharmaceuticals, focusing on rare diseases since September 2025. Previously, at Takeda, Ingrando held multiple senior roles, including Senior Director of IBD Strategy & Growth Marketing, where strategic initiatives led to significant increases in healthcare provider engagement and patient acquisitions. Earlier positions at Biogen included Associate Director for the US SPINRAZA brand team, contributing to a launch that exceeded $1 billion in revenue. Ingrando's career also includes leadership roles in training and development at Sanofi Renal, as well as commercial and sales positions across various pharmaceutical companies. Ingrando holds an MBA in Entrepreneurial Management and a B.S. in Marketing from Boston College.